Clinical Trial

Quantitative Pharmacology-Based Dose Adjustment Protocol in Postoperative Thyroid Cancer Patients

Name: Quantitative Pharmacology-Based Dose Adjustment Protocol in Postoperative Thyroid Cancer Patients — clinical trial record (NCT07752277)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

Through pharmacometric approaches-including modeling, mathematics, and statistics-this work aims to refine the levothyroxine sodium tablet (brand name: Euthyrox) dosing strategy in post-thyroidectomy cancer patients, enabling individualized precision dosing to minimize side effects and maximize therapeutic outcomes.

Trial Details

NCT Number	NCT07752277
Lead Sponsor	Zhejiang Provincial People's Hospital
Conditions	Thyroid Cancer
Enrollment	124 participants
Start Date	2022-12-06
Primary Completion	2026-02-23 (estimated)
Study Completion	2026-02-23 (estimated)
Updated on ClinicalTrials.gov	2026-08-13